Genomma Lab appoints Jorge Luis Brake Valderrama CEO, effective 10 September
Genomma Lab designa a Jorge Luis Brake Valderrama director general, a contar desde el 10 de septiembre
Intel ID : 264106
Relevant Documents
| Press Release | 23 Aug 2018 | Genomma_Lab_Nota_de_Prensa_2018.pdf (Source) | ES |
|
| Intel ID | 264106 | |
| Value | ND | |
| Native Currency |
Mexican Peso (MXN)
Exchange Rate:  |
|
|
Financial Data - Genomma Lab
(31 Dec 2017) |
Revenue: EUR 512,23m Exchange Rate:
|
|
| Date |
|
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
 |
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.